NO163957C - Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.

Info

Publication number
NO163957C
NO163957C NO855241A NO855241A NO163957C NO 163957 C NO163957 C NO 163957C NO 855241 A NO855241 A NO 855241A NO 855241 A NO855241 A NO 855241A NO 163957 C NO163957 C NO 163957C
Authority
NO
Norway
Prior art keywords
sup
carbapnam
relations
preparation
therapeutically active
Prior art date
Application number
NO855241A
Other languages
English (en)
Norwegian (no)
Other versions
NO163957B (no
NO855241L (no
Inventor
Yukio Sugimura
Toshihiko Hashimoto
Teruo Tanaka
Kimio Iino
Tomoyuki Shibata
Tetsuo Miyadera
Shinichi Sugawara
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO855241L publication Critical patent/NO855241L/no
Publication of NO163957B publication Critical patent/NO163957B/no
Publication of NO163957C publication Critical patent/NO163957C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NO855241A 1984-12-25 1985-12-23 Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. NO163957C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28170084 1984-12-25

Publications (3)

Publication Number Publication Date
NO855241L NO855241L (no) 1986-06-26
NO163957B NO163957B (no) 1990-05-07
NO163957C true NO163957C (no) 1990-08-15

Family

ID=17642759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855241A NO163957C (no) 1984-12-25 1985-12-23 Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.

Country Status (18)

Country Link
US (1) US4740507A (de)
EP (1) EP0186525B1 (de)
JP (1) JPS61275279A (de)
KR (1) KR930005332B1 (de)
CN (1) CN1014246B (de)
AT (1) ATE51624T1 (de)
AU (1) AU575232B2 (de)
CA (1) CA1254562A (de)
DE (1) DE3576957D1 (de)
DK (1) DK169384B1 (de)
ES (2) ES8706148A1 (de)
FI (1) FI81576C (de)
HU (1) HU196071B (de)
IE (1) IE58823B1 (de)
NO (1) NO163957C (de)
NZ (1) NZ214676A (de)
PH (1) PH25391A (de)
ZA (1) ZA859797B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
JPS6426580A (en) * 1987-07-21 1989-01-27 Sankyo Co Production of carbapenem derivative
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5286721A (en) * 1990-10-15 1994-02-15 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
TW209220B (de) * 1991-11-27 1993-07-11 Manyu Seiyaku Kk
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
JP2696807B2 (ja) * 1992-08-06 1998-01-14 田辺製薬株式会社 カルバペネム誘導体の製法
YU37299A (sh) * 1997-02-07 2002-06-19 Kyoto Pharmaceutical Industries Ltd. Karbapenemsko jedinjenje, njegova primena i njegovo intermedijarno jedinjenje
DE69932927D1 (de) 1998-05-01 2006-10-05 Kyoto Pharma Ind Cabapenemderivate, ihre anwendung und ihre zwischenprodukte
CZ296825B6 (cs) * 2001-05-21 2006-06-14 Kyoto Pharmaceutical Industries, Ltd. Karbapenemový derivát a antibakteriální cinidlo jej obsahující
GB0400382D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
US7932381B2 (en) * 2005-02-15 2011-04-26 Shionogi & Co., Ltd. Process for producing carbapenem derivative and intermediate crystal therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383946A (en) * 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
JPS5913757A (ja) * 1982-07-14 1984-01-24 Sankyo Co Ltd 3−メルカプトピロリジン誘導体及びその製法
JPS5916892A (ja) * 1982-07-19 1984-01-28 Sankyo Co Ltd カルバペネム−3−カルボン酸誘導体およびその製法
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS59205379A (ja) * 1983-05-09 1984-11-20 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物及びその製造法

Also Published As

Publication number Publication date
IE58823B1 (en) 1993-11-17
CN85109699A (zh) 1986-08-13
ES557035A0 (es) 1987-08-01
FI81576B (fi) 1990-07-31
AU5169985A (en) 1986-07-03
DK604485A (da) 1986-06-26
ATE51624T1 (de) 1990-04-15
ES8707535A1 (es) 1987-08-01
ZA859797B (en) 1986-09-24
NO163957B (no) 1990-05-07
EP0186525A1 (de) 1986-07-02
HUT39182A (en) 1986-08-28
CA1254562A (en) 1989-05-23
DK169384B1 (da) 1994-10-17
NO855241L (no) 1986-06-26
EP0186525B1 (de) 1990-04-04
AU575232B2 (en) 1988-07-21
FI81576C (fi) 1990-11-12
DK604485D0 (da) 1985-12-23
IE853300L (en) 1986-06-25
ES8706148A1 (es) 1987-06-01
FI855128A0 (fi) 1985-12-20
HU196071B (en) 1988-09-28
KR860004892A (ko) 1986-07-14
NZ214676A (en) 1988-06-30
JPS61275279A (ja) 1986-12-05
CN1014246B (zh) 1991-10-09
US4740507A (en) 1988-04-26
FI855128A (fi) 1986-06-26
KR930005332B1 (ko) 1993-06-17
ES550403A0 (es) 1987-06-01
DE3576957D1 (de) 1990-05-10
PH25391A (en) 1991-06-03

Similar Documents

Publication Publication Date Title
NO164980C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.
EP0219876A3 (en) Antihypertensive agents comprising 2-alkynyladenosines as active ingredients
DK291685D0 (da) Topisk behandling og praeparat
AU565898B2 (en) 1,8-naphthyridine derivatives
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
AU537028B2 (en) Imidazole derivatives
NO163957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.
EP0178189A3 (en) Pyridazinone derivatives, their preparation and use
YU30292A (sh) Nova aktivna jedinejnja
AU572978B2 (en) 1,5-benzothiazepine derivatives
ES8609272A1 (es) Un procedimiento para preparar derivados de hidantoina
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
IE792329L (en) Thiazaheterocyclics and process for preparing pyrrolidine¹and piperidine derivatives.
ES8607963A1 (es) "un procedimiento para la preparacion de derivados de imi- dazol triciclicos"
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
EP0151094A3 (de) Pharmakologisch aktive Imidazopyridinverbindungen
ES8403102A1 (es) Un procedimiento para la preparacion de esteres fluorofenoxibencilicos.
WO1989011472A1 (en) Substituted phenylalkylformamines and fungicidal preparation based thereon
ES8400443A1 (es) Mejoras introducidas en un procedimiento para la preparacion de hidroximidatos y tiolhidroximidatos heterobiciclicos y derivados ester carbamato de lso mismos.